TGFB1 and idiopathic pulmonary fibrosis: PFD is a small‐molecule inhibitor that is FDA‐approved for the treatment of idiopathic pulmonary fibrosis, and its mechanism of action is thought to include inhibition of TGF‐β1 activity.43